Navigation Links
Mapping Of Brain Highly Beneficial For Safer Brain Tumor Surgery

Mapping of brain during brain tumor surgery was found to be of much safer for patients by protecting them from the damage to speech and language centers, which happens// at times while performing such delicate surgeries.

According to researchers, "intraoperative language mapping" involves operating on an awake patient and mapping the anatomy of the patient's language function during the procedure. This helps surgeons identify which portions of the tumor can be safely removed without seriously damaging the patient's language function, states foodconsumer.org.

Dr. Nader Sanai and colleagues at the University of California, San Francisco studied 250 patients who underwent the surgeries to remove deadly glioma brain tumors and found that overall, 1.6 percent of the patients developed permanent postoperative language deficits.

"This series of patients represents the largest study to date examining intraoperative language mapping for gliomas, and supports the use of language mapping as the rule, rather than the exception, for dominant hemisphere gliomas," Sanai said.

"The findings support the conclusion that cortical language mapping may be used as a safe and efficient adjunct to optimize glioma resection while preserving essential language sites."


'"/>




Page: 1

Related medicine news :

1. Researchers from Emory University Undertake A New Genetic Mapping
2. Hunger Mapping
3. Project Aims at Mapping Genetic Changes Towards Cancer
4. Child-Proof: Brain Mapping Safer for Children than Previously Thought
5. India to Set Up Nicotine-Mapping Laboratory
6. Use of Cellular Phones associated with Increased risk of Brain Tumors
7. Brain death – How to cope with it
8. “Brain fingerprinting”- The new lie detectr
9. Nasal Spray Could Take Drugs Direct to Brain.
10. Virus Combats Brain Tumour
11. Nasal Spray Could Take Drugs Directly to Brain
Post Your Comments:
Other Medicine News:Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 2Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 3Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 4Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 5Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 6Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 7Health News:Cambridge Healthtech Media Group Launches Clinical Trials Web Site 2Health News:Cambridge Healthtech Media Group Launches Clinical Trials Web Site 3Health News:MainConcept Releases New Codec SDK 8.0 2Health News:MainConcept Releases New Codec SDK 8.0 3Health News:MainConcept Releases New Codec SDK 8.0 4Health News:Aetna Now Covers Novasys Medical's Renessa(R) Treatment for Incontinence in Women 2Health News:China Medical Technologies to Announce Financial Results for the Third Fiscal Quarter Ended December 31, 2008 on March 2, 2009 2Health News:Nothing But Nets and Union of Reform Judaism Help Save Lives in Kenya 2
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Within3 Expands into Mobile Applications 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 1IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 2New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 1New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 2New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 3New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 4Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 1Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 2Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 3Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 4